Hua Huang

Uppsala, C, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Pharmacological blocking of neutrophil extracellular traps attenuates immunothrombosis and neuroinflammation in cerebral cavernous malformation.

Pharmacological blocking of neutrophil extracellular traps attenuates immunothrombosis and neuroinflammation in cerebral cavernous malformation.

Journal: Nature cardiovascular research

Published: January 18, 2024

Single-cell dissection of the human blood-brain barrier and glioma blood-tumor barrier.

Single-cell dissection of the human blood-brain barrier and glioma blood-tumor barrier.

Journal: Neuron

Published: December 07, 2023

Wnt signaling regulates MFSD2A-dependent drug delivery through endothelial transcytosis in glioma.

Wnt signaling regulates MFSD2A-dependent drug delivery through endothelial transcytosis in glioma.

Journal: Neuro-oncology

Published: January 02, 2023

Correction: Inflammation and neutrophil extracellular traps in cerebral cavernous malformation.

Correction: Inflammation and neutrophil extracellular traps in cerebral cavernous malformation.

Journal: Cellular and molecular life sciences : CMLS

Published: May 30, 2022

Inflammation and neutrophil extracellular traps in cerebral cavernous malformation.

Inflammation and neutrophil extracellular traps in cerebral cavernous malformation.

Journal: Cellular and molecular life sciences : CMLS

Published: November 25, 2021

ELTD1 deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma.

ELTD1 deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma.

Journal: Neuro-oncology

Published: August 04, 2021

Key molecular alterations in endothelial cells in human glioblastoma uncovered through single-cell RNA sequencing.

Key molecular alterations in endothelial cells in human glioblastoma uncovered through single-cell RNA sequencing.

Journal: JCI insight

Published: April 27, 2021

Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma.

Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma.

Journal: Nature communications

Published: January 28, 2021

Fgfbp1 promotes blood-brain barrier development by regulating collagen IV deposition and maintaining Wnt/β-catenin signaling.

Fgfbp1 promotes blood-brain barrier development by regulating collagen IV deposition and maintaining Wnt/β-catenin signaling.

Journal: Development (Cambridge, England)

Published: September 30, 2019

Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy.

Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy.

Journal: Oncoimmunology

Published: July 26, 2019

Sunitinib enhances the antitumor responses of agonistic CD40-antibody by reducing MDSCs and synergistically improving endothelial activation and T-cell recruitment.

Sunitinib enhances the antitumor responses of agonistic CD40-antibody by reducing MDSCs and synergistically improving endothelial activation and T-cell recruitment.

Journal: Oncotarget

Published: November 11, 2015

Elevated expression of the C-type lectin CD93 in the glioblastoma vasculature regulates cytoskeletal rearrangements that enhance vessel function and reduce host survival.

Elevated expression of the C-type lectin CD93 in the glioblastoma vasculature regulates cytoskeletal rearrangements that enhance vessel function and reduce host survival.

Journal: Cancer research

Published: December 17, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026